Encephalitis, Arbovirus: Clinical Trials

147 trials for Encephalitis, Arbovirus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

105 completed, 19 unknown, 7 recruiting, 5 not yet recruiting. 42 Phase 3, 36 Phase 2, 31 Phase 4, 15 Phase 1, 5 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 342Completed 39, Unknown 2, Recruiting 1
Phase 236Completed 24, Unknown 7, Terminated 2, Active not recruiting 1, Not yet recruiting 1, Recruiting 1
Phase 431Completed 26, Unknown 4, Active not recruiting 1
Phase 115Completed 9, Not yet recruiting 2, Withdrawn 2, Terminated 1, Unknown 1
Not applicable5Completed 2, Not yet recruiting 1, Recruiting 1, Unknown 1

Follow Encephalitis, Arbovirus: new trials by email Literature Review of Encephalitis, Arbovirus trials Research Report on Encephalitis, Arbovirus

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
First-in-Human Study Testing a New Antibody Treatment for Tick-Borne Encephalitis in Healthy Volunteers.
Human monoclonal antibody TBE025, intravenous infusion - The Tick-borne Encephalitis Virus (TBEV)
Phase 1Not yet recruitingGiuseppe Pantaleo182026-01-012026-01-29
Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Dengue, Chikungunya
RecruitingInstitut Pasteur du Cambodge100002025-12-182026-01-22
Diagnostics and Surveillance of Acute Meningo-encephalitis Among Children in Cambodia With a Focus on Japanese Encephalitis Virus
Japanese Encephalitis
Not yet recruitingANRS, Emerging Infectious Diseases40002025-10-152025-09-11
A Phase 1 Study Evaluating the Safety, Tolerability, and Immunogenicity of V4020 Vaccine in Healthy Volunteers
V4020 - Venezuelan Equine Encephalitis, Venezuelan Equine Encephalitis Virus Infection
Phase 1Not yet recruitingMedigen, Inc.392025-08-152025-07-28
High-Titer Neutralizing Plasma for West Nile Fever in Hospitalized Patients
Plasma - West Nile Fever
Phase 2RecruitingGili Regev-Yochay MD372025-07-302025-08-26
FINtick - a Prospective Multicenter Study on Tick-borne Infections in Finland
Tick Borne Encephalitis (TBE), Lyme Borreliosis
RecruitingTurku University Hospital8502025-04-232026-10-27
A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV Vaccine
MVA-BN-WEV, Placebo - Encephalitis
Phase 2Active not recruitingBavarian Nordic4112025-03-102025-10-01
Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases
Peripheral venous blood sample - Leishmaniasis, Leptospirosis
Not applicableNot yet recruitingUniversity Hospital, Montpellier1832025-03-032025-03-05
A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults
GBP560-A, GBP560-B, IXIARO - Japanese Encephalitis Virus Disease
Phase 1 / Phase 2CompletedSK Bioscience Co., Ltd.1612025-02-242026-09-11
Monitoring JE Antibody Levels in Healthy Populations and Immunization Strategy in Low-Prevalence Areas
Liaoning Chengda Inactivated Japanese Encephalitis Vaccine - Japanese Encephalitis
Phase 4Active not recruitingLiaoning Chengda Biotechnology CO., LTD2502024-11-142024-12-13
Early Interferon-beta Treatment for West-Nile Virus Infection
Rebif 44 MCG Per 0.5 ML Prefilled Syringe, Saline - West Nile Virus, West Nile Fever Encephalitis
Phase 2UnknownTel-Aviv Sourasky Medical Center1002024-07-142024-07-23
Dexamethasone in Tick-borne Encephalitis
Dexametasone, Saline (0.9% NaCl) - Tick-Borne Encephalitis
Phase 3RecruitingUniversity Medical Centre Ljubljana2002024-05-032026-05-13
Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR)
Vero cell-drived inactive Japanese encephalitis vaccine, Measles-Mumps-Rubella Vaccine - Japanese Encephalitis, Measles
Phase 4CompletedLiaoning Chengda Biotechnology CO., LTD4082024-03-022025-08-28
Evaluation of Knowledge on Tick-borne Encephalitis Virus (TBEV) Infection Among General Practitioners in France
Tick-borne Encephalitis, France
RecruitingUniversity Hospital, Strasbourg, France1002024-02-162025-09-24
Safety Observation of the Japanese Encephalitis Vaccine Given With a Primary Immunization
Japanese Encephalitis
CompletedLiaoning Chengda Biotechnology CO., LTD153572024-01-012025-08-28
Primary TBE Vaccination for the Elderly
FSME-IMMUN Vaccine - Tick-borne Encephalitis, Vaccine
Phase 4UnknownRegion Örebro County902024-01-012023-11-18
Tick-borne Encephalitis Virus Research in Limousin
anti-TBEV serology - Tick-borne Encephalitis
CompletedUniversity Hospital, Limoges8782023-07-172026-04-08
Burden of Tick-borne Encephalitis and Cost-effectiveness of Vaccination in the Czech Republic
No intervention - Tick Borne Encephalitis (TBE)
RecruitingCharles University, Czech Republic2092023-04-012025-12-10
Prevalence of Tick-borne Encephalitis in the Pediatric Population Treated at the HUS and Characterization of Confirmed Pediatric Cases
Tick-borne Encephalitis
CompletedUniversity Hospital, Strasbourg, France5002022-10-242026-10-23
Management of Tick-borne Encephalitis
No Intervention: Observational Cohort - Infectious Encephalitis
CompletedUniversity Medical Centre Ljubljana3182022-09-302024-12-13

Showing 20 of 147. Sign in to see all of them.

Narrower conditions

Encephalitis, Japanese (72)  ·  Encephalitis, Tick-Borne (51)  ·  Encephalitis (14)  ·  West Nile Fever (12)  ·  Encephalomyelitis, Venezuelan Equine (8)  ·  Measles (5)  ·  Rubella (5)  ·  Virus Diseases (5)  ·  Yellow Fever (5)  ·  Mumps (4)  ·  Alphavirus Infections (3)  ·  Chickenpox (3)  ·  Encephalomyelitis, Eastern Equine (3)  ·  Encephalomyelitis, Equine (3)  ·  Hepatitis A (3)

Broader conditions

Arbovirus Infections (147)  ·  Infections (147)  ·  Neuroinflammatory Diseases (147)  ·  Brain Diseases (146)  ·  Central Nervous System Diseases (146)  ·  Central Nervous System Infections (146)  ·  Central Nervous System Viral Diseases (146)  ·  Encephalitis, Viral (146)  ·  RNA Virus Infections (146)  ·  Vector Borne Diseases (146)  ·  Infectious Encephalitis (145)  ·  Nervous System Diseases (145)  ·  Virus Diseases (142)  ·  Flaviviridae Infections (134)

Interventions

Japanese Encephalitis Vaccines (10)  ·  Vaccines (10)  ·  Blood Specimen Collection (5)  ·  Desiccation (3)  ·  Doxycycline (3)  ·  FSME-IMMUN vaccine (3)  ·  Hepatitis A Vaccines (3)  ·  Saline Solution (3)  ·  Surveys and Questionnaires (3)  ·  Measles-Mumps-Rubella Vaccine (2)  ·  SA-14-14-2 vaccine (2)  ·  Sodium Chloride (2)  ·  Yellow Fever Vaccine (2)  ·  Acyclovir (1)  ·  Ceftriaxone (1)

Sponsors

Pfizer (19)  ·  Valneva Austria GmbH (15)  ·  Sanofi Pasteur, a Sanofi Company (13)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (7)  ·  PATH (7)  ·  Sanofi (7)  ·  University Medical Centre Ljubljana (7)  ·  U.S. Army Medical Research and Development Command (6)  ·  Novartis (5)  ·  Liaoning Chengda Biotechnology CO., LTD (3)  ·  Medical University of Vienna (3)  ·  National Institute of Hygiene and Epidemiology, Vietnam (3)  ·  Bavarian Nordic (2)  ·  Boryung Pharmaceutical Co., Ltd (2)  ·  MacroGenics (2)

Countries

United States (26)  ·  Germany (18)  ·  Austria (17)  ·  Poland (9)  ·  China (8)  ·  Thailand (8)  ·  Australia (7)  ·  Philippines (7)  ·  Slovenia (7)  ·  Czechia (5)  ·  South Korea (5)  ·  Vietnam (5)  ·  France (4)  ·  Sweden (4)  ·  Finland (3)

Top investigators

Astrid Kaltenboeck, Ph.D. (3)  ·  Ryszard Konior, MD (3)  ·  Thiem D Vu, MD., PhD. (3)  ·  Anna Durbin, MD (2)  ·  Anthony Cardile, DO (2)  ·  Huanyu Wang (2)  ·  Jerzy Brzostek, MD (2)  ·  Jerzy Dziduch, MD (2)  ·  Jerzy Romaszko, MD (2)  ·  Krzysztof Sladek, MD (2)

Results publications

PMID 20934459, PMID 21592984, PMID 28545923, PMID 15714427, PMID 18190252, PMID 18394765, PMID 19143532, PMID 20856164, PMID 20864814, PMID 21148499, PMID 21150279, PMID 21288804, PMID 21398392, PMID 22696017, PMID 22777096, PMID 23967083, PMID 24656175, PMID 24717964, PMID 24873986, PMID 25239483, PMID 25308927, PMID 25483480, PMID 25567119, PMID 25728316, PMID 25872531, PMID 25886645, PMID 26005163, PMID 26994987, PMID 27206386, PMID 27628323, PMID 27686833, PMID 27815383, PMID 27903416, PMID 28135273, PMID 29081368, PMID 29325161, PMID 29429815, PMID 30833160, PMID 30928173, PMID 30962094, PMID 32156630, PMID 32474892, PMID 32528467, PMID 32728481, PMID 33763778, PMID 33899755, PMID 34452033, PMID 35101266, PMID 35243320, PMID 35568049

NIH funding

2008 (1), 2009 (1)